Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
LAG-3 and TIGIT expression may predict skin melanoma progression and survival. Discover how these immune markers could shape future therapies. Read more.
If these results are validated by prospective trials, it could become a valuable tool for oncologists to assess results ...
Can you define the characteristics of the four stages of cancer? I understand that stage I is generally when cancer is caught early and can be treated with a good success rate, while stage IV is ...
Disparities in diagnosis and access to care were more significant in AI/AN patients than in White patients with malignant melanoma.
A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results